Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
Enter promotional code 05984 at checkout.
Out of Stock
|(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)|
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
By John J Cush, Chief, Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas
Clinical Professor of Internal Medicine, and Kathryn H. Dao
- 240 Pages
- Imprint: Saunders
- ISBN: 978-1-4557-5065-8
- Copyright: 2012